These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 29583121

  • 1. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H, Tyagi P, Medapi B, Krishna VS, Sriram D, Khanna N, Swaminathan S.
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [Abstract] [Full Text] [Related]

  • 2. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
    Raut R, Beesetti H, Tyagi P, Khanna I, Jain SK, Jeankumar VU, Yogeeswari P, Sriram D, Swaminathan S.
    Virol J; 2015 Feb 08; 12():16. PubMed ID: 25886260
    [Abstract] [Full Text] [Related]

  • 3. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA.
    Antivir Chem Chemother; 2011 May 12; 21(5):209-17. PubMed ID: 21566267
    [Abstract] [Full Text] [Related]

  • 4. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.
    Leonel CA, Lima WG, Dos Santos M, Ferraz AC, Taranto AG, de Magalhães JC, Dos Santos LL, Ferreira JMS.
    Arch Virol; 2018 Mar 12; 163(3):575-586. PubMed ID: 29147793
    [Abstract] [Full Text] [Related]

  • 5. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH, Ali A, Rusere L, Soumana DI, Kurt Yilmaz N, Schiffer CA.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28298600
    [Abstract] [Full Text] [Related]

  • 6. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J, Hammamy MZ, Epp A, Hardes K, Kallis S, Zhang L, Hilgenfeld R, Bartenschlager R, Steinmetzer T.
    J Enzyme Inhib Med Chem; 2017 Dec 15; 32(1):712-721. PubMed ID: 28385094
    [Abstract] [Full Text] [Related]

  • 7. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H, Teramoto T, Padmanabhan R.
    Methods Mol Biol; 2014 Dec 15; 1138():345-60. PubMed ID: 24696347
    [Abstract] [Full Text] [Related]

  • 8. Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase.
    Byrd CM, Grosenbach DW, Berhanu A, Dai D, Jones KF, Cardwell KB, Schneider C, Yang G, Tyavanagimatt S, Harver C, Wineinger KA, Page J, Stavale E, Stone MA, Fuller KP, Lovejoy C, Leeds JM, Hruby DE, Jordan R.
    Antimicrob Agents Chemother; 2013 Apr 15; 57(4):1902-12. PubMed ID: 23403421
    [Abstract] [Full Text] [Related]

  • 9. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
    Panya A, Songprakhon P, Panwong S, Jantakee K, Kaewkod T, Tragoolpua Y, Sawasdee N, Lee VS, Nimmanpipug P, Yenchitsomanus PT.
    Molecules; 2021 May 23; 26(11):. PubMed ID: 34071102
    [Abstract] [Full Text] [Related]

  • 10. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
    Wu DW, Mao F, Ye Y, Li J, Xu CL, Luo XM, Chen J, Shen X.
    Acta Pharmacol Sin; 2015 Sep 23; 36(9):1126-36. PubMed ID: 26279156
    [Abstract] [Full Text] [Related]

  • 11. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
    Xu HT, Colby-Germinario SP, Hassounah S, Quashie PK, Han Y, Oliveira M, Stranix BR, Wainberg MA.
    Antimicrob Agents Chemother; 2016 Jan 23; 60(1):600-8. PubMed ID: 26574011
    [Abstract] [Full Text] [Related]

  • 12. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
    Qamar MT, Ashfaq UA, Tusleem K, Mumtaz A, Tariq Q, Goheer A, Ahmed B.
    Pak J Pharm Sci; 2017 Nov 23; 30(6):2119-2137. PubMed ID: 29175781
    [Abstract] [Full Text] [Related]

  • 13. Exploring antiviral activity of Betanin and Glycine Betaine against dengue virus type-2 in transfected Hela cells.
    Mufti IU, Ain QU, Malik A, Shahid I, Alzahrani AR, Ijaz B, Rehman S.
    Microb Pathog; 2024 Oct 23; 195():106894. PubMed ID: 39214424
    [Abstract] [Full Text] [Related]

  • 14. Novel dengue virus NS2B/NS3 protease inhibitors.
    Wu H, Bock S, Snitko M, Berger T, Weidner T, Holloway S, Kanitz M, Diederich WE, Steuber H, Walter C, Hofmann D, Weißbrich B, Spannaus R, Acosta EG, Bartenschlager R, Engels B, Schirmeister T, Bodem J.
    Antimicrob Agents Chemother; 2015 Feb 23; 59(2):1100-9. PubMed ID: 25487800
    [Abstract] [Full Text] [Related]

  • 15. Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors.
    Akaberi D, Båhlström A, Chinthakindi PK, Nyman T, Sandström A, Järhult JD, Palanisamy N, Lundkvist Å, Lennerstrand J.
    Antiviral Res; 2021 Jun 23; 190():105074. PubMed ID: 33872674
    [Abstract] [Full Text] [Related]

  • 16. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes.
    Hassandarvish P, Oo A, Jokar A, Zukiwski A, Proniuk S, Abu Bakar S, Zandi K.
    J Antimicrob Chemother; 2017 Sep 01; 72(9):2438-2442. PubMed ID: 28666323
    [Abstract] [Full Text] [Related]

  • 17. Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation.
    Kiemel D, Kroell AH, Denolly S, Haselmann U, Bonfanti JF, Andres JI, Ghosh B, Geluykens P, Kaptein SJF, Wilken L, Scaturro P, Neyts J, Van Loock M, Goethals O, Bartenschlager R.
    Nat Commun; 2024 Jul 19; 15(1):6080. PubMed ID: 39030239
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I, Geluykens P, Clynhens M, Strijbos R, Goethals O, Megens S, Verheyen N, Last S, McGowan D, Coesemans E, De Boeck B, Stoops B, Devogelaere B, Pauwels F, Vandyck K, Berke JM, Raboisson P, Simmen K, Lory P, Van Loock M.
    Antiviral Res; 2017 Nov 19; 147():149-158. PubMed ID: 29037976
    [Abstract] [Full Text] [Related]

  • 19. Identification of covalent active site inhibitors of dengue virus protease.
    Koh-Stenta X, Joy J, Wang SF, Kwek PZ, Wee JL, Wan KF, Gayen S, Chen AS, Kang C, Lee MA, Poulsen A, Vasudevan SG, Hill J, Nacro K.
    Drug Des Devel Ther; 2015 Nov 19; 9():6389-99. PubMed ID: 26677315
    [Abstract] [Full Text] [Related]

  • 20. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z, Sakamuru S, Huang R, Brecher M, Koetzner CA, Zhang J, Chen H, Qin CF, Zhang QY, Zhou J, Kramer LD, Xia M, Li H.
    Antiviral Res; 2018 Feb 19; 150():217-225. PubMed ID: 29288700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.